ctrl K

NRx Pharmaceuticals Inc. (NRXP)

NASDAQ: NRXP · Real-Time Price · USD

2.06

-0.02 (-0.96%)

At close: May 02, 2025, 3:59 PM

2.08

0.73%

After-hours: May 02, 2025, 05:47 PM EDT

NRx Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	5K	4K	2K	907.41K	n/a	1.01M	n/a
Gross Profit	n/a	-5K	-4K	-2K	-907.41K	n/a	-1.01M	n/a
Operating Income	-18.5M	-27.59M	-44.4M	-115.8M	-51.39M	-6.26K	-1.01M	n/a
Interest Income	-44K	494K	249K	18.00	56.00	1.21M	1.09M	n/a
Pretax Income	-25.13M	-30.16M	-39.82M	-93.06M	-51.78M	492.63K	82.41K	-105.03K
Net Income	-25.13M	-30.15M	-35.23M	-71.72M	-12.35M	408.43K	66.1K	-105.03K
Selling & General & Admin	13.51M	14.21M	27.37M	74.94M	11.44M	2.77K	1.01M	n/a
Research & Development	6.2M	13.37M	17.03M	20.26M	10.63M	3.5K	n/a	n/a
Other Expenses	n/a	n/a	-505K	-771K	-10.16M	713.19K	1.01M	n/a
Operating Expenses	19.7M	27.58M	44.4M	94.43M	11.9M	6.43K	1.01M	n/a
Interest Expense	230K	120K	n/a	18K	56K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-5K	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	27.59M	44.4M	94.43M	11.9M	6.43K	1.01M	n/a
Income Tax Expense	n/a	-9K	-4.58M	-21.35M	-39.43M	84.21K	16.31K	n/a
Shares Outstanding (Basic)	10.52M	7.58M	65.77M	46.92M	34.27M	508.83K	892.5K	903.55K
Shares Outstanding (Diluted)	10.52M	7.58M	65.77M	46.92M	34.27M	508.83K	892.5K	903.55K
EPS (Basic)	-2.39	-3.98	-0.54	-1.53	-0.36	0.80	0.07	-0.12
EPS (Diluted)	-2.39	-3.98	-0.54	-1.53	-0.36	0.80	0.07	-0.12
EBITDA	-18.5M	-30.02M	-39.75M	-93.04M	-51.72M	-713.19K	82.41K	-105.04K
EBIT	-24.9M	-30.03M	-39.75M	-93.05M	-51.72M	n/a	82.41K	-105.04K
Depreciation & Amortization	6.39M	5K	4K	2K	2K	0.86	1.09M	52.52K